Komodo Health today announced the promotions of Richard Kho, Ph.D., as chief revenue officer and Saiba Sabherwal, M.B.A., as chief financial officer. In addition, the company announced the strategic hire of Julie Rogers as vice president of people & experience.
Dr. Richard Kho moves into the chief revenue officer from his most recent position as Komodo’s head of life sciences. He will lead the customer team and oversee sales, account management, and customer success functions. His 18-plus years of experience includes roles at Genentech and Onyx Pharmaceuticals.
Previously the head of operations at Komodo, Saiba Sabherwal will lead all financial functions. She has more than 15 years of experience in the financial services and tech industries, including senior roles at Google, Spotify, and Pandora, where she helped scale the company for its initial public offering.
“Richard and Saiba have been integral in the growth of Komodo Health over the last seven years,” said Komodo Health CEO and Co-Founder Arif Nathoo, M.D. “Richard has a keen understanding of the life sciences and is a trusted partner to our clients. Saiba is an expert financial advisor who has helped manage our growth plan and brings tremendous Software as a Service-related expertise. We are thrilled to have them in their new executive roles.”
Komodo Health also welcomed Vice President of People & Experience Julie Rogers. She will oversee all human resources functions and is responsible for innovating culture initiatives and motivating team members to find success within the company. Rogers has more than 20 years of HR knowledge and leadership from positions at Culture Amp, Atlassian, and AdRoll.
“Culture at Komodo Health is at its core about believing that our people are instrumental to our business success,” said Nathoo. “We believe strongly that talented people only thrive in a healthy and challenging environment, and Julie comes to us with a great reputation for fostering and guiding motivated, high-performance teams.”
Komodo Health, a McKesson Ventures portfolio company, is a healthcare AI company focused on improving patient outcomes and reducing global burden of disease through the largest, most representative, and timeliest healthcare map.
Read the original press release here.